| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/09/2005 | WO2005051325A2 Carvedilol compositions methods of treatment and delivery |
| 06/09/2005 | WO2005051322A2 Controlled release pharmaceutical formulations comprising carvedilol, free based and its salts |
| 06/09/2005 | WO2005051305A2 Enhanced drug delivery |
| 06/09/2005 | WO2005051290A2 Methods and formulations for the treatment of medical conditions related to elevated dihydrotestosterone |
| 06/09/2005 | WO2005051234A2 Injectable sustained release implant having a bioerodible matrix core and a bioerodible skin |
| 06/09/2005 | WO2005051232A2 Soft tissue implants and anti-scarring agents |
| 06/09/2005 | WO2005051176A2 Hemostatic pressure plug |
| 06/09/2005 | WO2005034919A3 Method of producing dosage units of a solid drug form containing warfarin sodium salt as active component |
| 06/09/2005 | WO2005034854A3 Water dispersible film |
| 06/09/2005 | WO2005033181A3 Telechelic homopolyamino acids functionalized by hydrophobic groups and uses, particularly therapeutic, thereof |
| 06/09/2005 | WO2005025500A3 Process for preparing water soluble diterpenes and their applications |
| 06/09/2005 | WO2005020933A3 Nanoparticles for drug-delivery |
| 06/09/2005 | WO2005020876A3 Pharmaceutical composition, method of manufacturing and therapeutic use thereof |
| 06/09/2005 | WO2005011579A3 Treatment of dependence withdrawal |
| 06/09/2005 | WO2005009364A3 Antibiotic product, use and formulation thereof |
| 06/09/2005 | WO2005009356A3 Method for the preparation of controlled release formulations |
| 06/09/2005 | WO2005009276A3 Microbial cellulose wound dressing |
| 06/09/2005 | WO2005002510A3 Deployable multifunctional hemostatic agent |
| 06/09/2005 | WO2004105737A3 Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions using various agents |
| 06/09/2005 | WO2004041118A8 Therapeutic compositions for drug delivery to and through covering epithelia |
| 06/09/2005 | WO2004038428A3 Controlled-release compositions |
| 06/09/2005 | WO2004034982A3 Treatment termination in a medical device |
| 06/09/2005 | WO2004033483A3 Liposomal system and method of using same |
| 06/09/2005 | US20050124980 Port stem marking for catheter placement |
| 06/09/2005 | US20050124979 Miniaturized device; substrate with reservoirs; aperture; barrier covering; sustained release |
| 06/09/2005 | US20050124862 Thyroid hormone analogs and methods of use |
| 06/09/2005 | US20050124743 Hybrid system for solubilizing pharmaceutically active substances in polymer matrices |
| 06/09/2005 | US20050124702 Using tricine; antiseptic for contact lenses; artificial tears |
| 06/09/2005 | US20050124699 Drugs for treating or preventing disorders of corneal and/or conjunctival epithelial cells |
| 06/09/2005 | US20050124697 Topical applying to skins; sunscreen agents; anticancer agents; using arylpropionic acid |
| 06/09/2005 | US20050124663 Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes |
| 06/09/2005 | US20050124651 Solid pharmaceutical preparation |
| 06/09/2005 | US20050124644 Inhalers used in the treatment of respiratory system disorders, such as chronic obstructive pulmonary disease and asthma |
| 06/09/2005 | US20050124595 Administering an indole diterpene from the fungus strain of Chaunopycnis pustulata to relieve ocular pressure and provide neuroprotection; potent potassium channel and maxi-K channel blockers; side effect reduction; nonneurotoxic; antiedema agents |
| 06/09/2005 | US20050124591 Use of vitamin Ds to treat kidney disease |
| 06/09/2005 | US20050124589 New use, pharmaceutical preparations as well as a process for their production |
| 06/09/2005 | US20050124578 Aqueous compositions containing metronidazole |
| 06/09/2005 | US20050124571 Exposure a suspension of active agents such as viral vector and microparticles to condition which results in greater efficiency; injecting mixture, then removal of microparticles |
| 06/09/2005 | US20050124561 Administering fungicide for mucous membrane; asthma therapy |
| 06/09/2005 | US20050124558 Controlling particle size; bioavailability |
| 06/09/2005 | US20050124546 Oligopeptide lyophilisate, their preparation and use |
| 06/09/2005 | US20050124069 Transfection reagents |
| 06/09/2005 | US20050124036 Method for producing recombinant proteins in micro-organisms |
| 06/09/2005 | US20050123962 Regulated nucleic acids in pathogenesis of alzheimer's disease |
| 06/09/2005 | US20050123897 Controlling flux of penetrants across adaptable, semipermeable porous barrier by enlarging applied dose per area; drug delivery kits, patches |
| 06/09/2005 | US20050123635 Cannabis aerosol |
| 06/09/2005 | US20050123627 an alkalizing agent; and multiparticulates containing about 20% to 75% azithromycin, and, about 25% to 80% of a glyceride which comprises glyceryl monobehenate, glyceryl dibehenate, glyceryl tribehenate and a poloxamer |
| 06/09/2005 | US20050123625 Compositions for treatment of viral-induced skin lesions and methods of using same |
| 06/09/2005 | US20050123618 Method of producing micro-capsules for the sustained release of drugs |
| 06/09/2005 | US20050123617 Biodegradable polymeric nanocapsules and uses thereof |
| 06/09/2005 | US20050123616 Azithromycin multiparticulate dosage forms by liquid-based processes |
| 06/09/2005 | US20050123615 Controlled release dosage forms of azithromycin |
| 06/09/2005 | US20050123614 Microparticles |
| 06/09/2005 | US20050123613 Used for intravenous transfusion; compatibility with tissues, have no toxicity or side effect, have no harmful stimulation, have no immunogenicity |
| 06/09/2005 | US20050123612 Ribavirin granulate for producing coated tablets |
| 06/09/2005 | US20050123611 Has an active material substantially homogeneously dispersed throughout the particles and wherein the active material is capable of being released from particles |
| 06/09/2005 | US20050123610 Composition of a polypeptide and an amphiphilic compound in an ionic complex and the use thereof |
| 06/09/2005 | US20050123609 Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration |
| 06/09/2005 | US20050123608 Preparation of powder agglomerate |
| 06/09/2005 | US20050123607 Pharmaceutical formulation of valaciclovir |
| 06/09/2005 | US20050123606 Compositions of quaternary ammonium compounds containing bioavailability enhancers |
| 06/09/2005 | US20050123605 Anticancer agents; prevent forming blood vessels; removal blockage |
| 06/09/2005 | US20050123604 Comprise 5-methyl-2-(2'-chloro-6'-fluoroanilino)phenylacetic acid; cyclooxygenase-2 dependent disorder |
| 06/09/2005 | US20050123603 Oral delivery vehicle; food products |
| 06/09/2005 | US20050123602 Includes micelle-forming excipient; increases oral bioavailability; Chlamydia pneumoniae |
| 06/09/2005 | US20050123601 Envelope of film forming, water soluble polymer enclosing a core; mixture containing plasticizer and acid; food, drugs, oral hygiene, cosmetics |
| 06/09/2005 | US20050123600 Compositions and methods for drug delivery using pH sensitive molecules |
| 06/09/2005 | US20050123599 Oil-in-water adjuvant of water, MF59, a steroid and a saponin; vaccine |
| 06/09/2005 | US20050123598 Phospho-amino acid end groups interact with receptors on antigen-presenting cells; for treatment of T-cell mediated disorders (autoimmune conditions), inflammatory disorders, neurodegenerative disorders, and endothelial dysfunction disorders; liposomes; kits |
| 06/09/2005 | US20050123597 Releasable linkage and compositions containing same |
| 06/09/2005 | US20050123596 pH-triggered microparticles |
| 06/09/2005 | US20050123595 Composition for removing tattoos |
| 06/09/2005 | US20050123594 contacting a liposome ( lectin, glycolipid, phospolipid) with RLIP76 protein to create a proteoliposome; detoxifies xenobiotics by a process that catalyzes ATP; protection against toxic by-products of metabolism, stress, and drugs |
| 06/09/2005 | US20050123593 Chondroitin sulfate, keratinsulphate, heparin, heparin sulfate and dermatan sulfate encapsulated in a bilayer forming dipalmitoylphosphatidylcholine phospholipid; dosage; osteoarthritis |
| 06/09/2005 | US20050123592 Pharmaceutical compositions and methods for insulin treatment |
| 06/09/2005 | US20050123588 Hemostatic agent ( microporous polysaccharide microspheres) and a therapeutic agent deposited on chitosan a hemostatic substrate for controlling bleeding caused by surgery or traumatic injuries |
| 06/09/2005 | US20050123576 Mupirocin compositions for topical use, an improved process of making same and methods of using same |
| 06/09/2005 | US20050123575 Heating, cooling, reheating and recooling a mixture containing hard fat while stirring; cosmetics, cosmeceutical, pharmaceutical; second temperature is lower than the congelation temperature of the mixture; hard fat is a mixture of triester of glycerin with caprylic, capric and stearic acids |
| 06/09/2005 | US20050123565 System and method for transdermal vaccine delivery |
| 06/09/2005 | US20050123563 Lipoparticles comprising proteins, methods of making, and using the same |
| 06/09/2005 | US20050123527 drug delivery devices comprising multicompartments containing dry nonpathogenic bacterial strains, used for treating gastrointestinal disorders |
| 06/09/2005 | US20050123523 Immunostimulatory nucleic acid molecules |
| 06/09/2005 | US20050123522 Monocyte-derived dendritic cell subsets |
| 06/09/2005 | US20050123509 Modulating charge density to produce improvements in the characteristics of spray-dried proteins |
| 06/09/2005 | US20050123507 Formulations for coated microprojections having controlled solubility |
| 06/09/2005 | US20050123489 Medicated chewing gum delivery system for nicotine |
| 06/09/2005 | US20050123486 inhalers used in the treatment of respiratory system disorders, such as chronic obstructive pulmonary disease and asthma |
| 06/09/2005 | US20050123485 fluidization and spraying powders with gases using microtubes, to target sites: hemostatic agents; preventing biological adhesions and wound healing agents |
| 06/09/2005 | US20050123484 comprising a concentrate of a local anesthetic in a non-alcohol solvent and a hydrofluorocarbon propellant, used for for accurate metered dose delivery |
| 06/09/2005 | US20050123482 Temperature activated gaseous liposomes; therapy drug delivery; accumulating in cancer and disease tissue |
| 06/09/2005 | US20050123481 Radio-opaque polymeric biomaterials |
| 06/09/2005 | US20050121814 Microencapsulation system and method |
| 06/09/2005 | US20050121388 Production of water for injection using reverse osmosis |
| 06/09/2005 | US20050121032 Pre-metered dry powder inhaler for moisture-sensitive medicaments |
| 06/09/2005 | US20050121027 Inhalable tiotropium and container therefor |
| 06/09/2005 | US20050121026 Method for administration of tiotropium |
| 06/09/2005 | DE10353310A1 Verwendung einer Lösung mit mindestens einem nichtionischen Tensid Use of a solution with at least one non-ionic surfactant |
| 06/09/2005 | DE10351644A1 Verfahren zur Herstellung von lagerstabilen multiplen Emulsionen Process for the preparation of storage-stable multiple emulsions |
| 06/09/2005 | DE10351448A1 Geschmackstoffhaltige Arzneimittelformulierungen mit verbesserten pharmazeutischen Eigenschaften Flavor-containing drug formulations with improved pharmaceutical properties |
| 06/09/2005 | DE10350528A1 Arzneimittelformulierung, enthaltend einen LTB4-Antagonisten, sowie Verfahren zu deren Herstellung und deren Verwendung Pharmaceutical formulation comprising a LTB4 antagonist, and methods for their preparation and their use |